BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17827264)

  • 1. Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival.
    Spiegelstein D; Kim C; Zhang Y; Li G; Weisel RD; Li RK; Yau TM
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3311-6. PubMed ID: 17827264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing ventricular function with multimodal cell-based gene therapy.
    Yau TM; Kim C; Li G; Zhang Y; Weisel RD; Li RK
    Circulation; 2005 Aug; 112(9 Suppl):I123-8. PubMed ID: 16159803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced angiogenesis with multimodal cell-based gene therapy.
    Yau TM; Kim C; Li G; Zhang Y; Fazel S; Spiegelstein D; Weisel RD; Li RK
    Ann Thorac Surg; 2007 Mar; 83(3):1110-9. PubMed ID: 17307468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and growth factor expression in a model of transmyocardial revascularization.
    Pelletier MP; Giaid A; Sivaraman S; Dorfman J; Li CM; Philip A; Chiu RC
    Ann Thorac Surg; 1998 Jul; 66(1):12-8. PubMed ID: 9692432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmyocardial revascularization and vascular endothelial growth factor administration enhance effect of cell transplantation for myocardial infarct repair in rats.
    Wang Y; Dong Y; Li R; Wang D; Tang H; Liu W; Zhang X
    Coron Artery Dis; 2006 May; 17(3):275-81. PubMed ID: 16728879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
    Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced myocardial angiogenesis by gene transfer with transplanted cells.
    Yau TM; Fung K; Weisel RD; Fujii T; Mickle DA; Li RK
    Circulation; 2001 Sep; 104(12 Suppl 1):I218-22. PubMed ID: 11568059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cytoprotection and angiogenesis by bone marrow cell transplantation may contribute to improved ischemic myocardial function.
    Zhang S; Zhang P; Guo J; Jia Z; Ma K; Liu Y; Zhou C; Li L
    Eur J Cardiothorac Surg; 2004 Feb; 25(2):188-95. PubMed ID: 14747111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF-C-kit and SDF-1-CXCR4 Signaling Axes.
    Shahzad U; Li G; Zhang Y; Li RK; Rao V; Yau TM
    Stem Cell Rev Rep; 2015 Apr; 11(2):332-46. PubMed ID: 25420576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.
    Reboll MR; Korf-Klingebiel M; Klede S; Polten F; Brinkmann E; Reimann I; Schönfeld HJ; Bobadilla M; Faix J; Kensah G; Gruh I; Klintschar M; Gaestel M; Niessen HW; Pich A; Bauersachs J; Gogos JA; Wang Y; Wollert KC
    Circulation; 2017 Nov; 136(19):1809-1823. PubMed ID: 28931551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization.
    Yamamoto N; Kohmoto T; Roethy W; Gu A; DeRosa C; Rabbani LE; Smith CR; Burkhoff D
    Basic Res Cardiol; 2000 Feb; 95(1):55-63. PubMed ID: 10752546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with transmyocardial revascularization might improve ischemic myocardial function performed with cell transplantation.
    Wang Y; Tang H; Wang D; Li R; Dong Y; Liu W; Zhang X
    Circ J; 2006 May; 70(5):625-30. PubMed ID: 16636501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.
    Jamaiyar A; Wan W; Ohanyan V; Enrick M; Janota D; Cumpston D; Song H; Stevanov K; Kolz CL; Hakobyan T; Dong F; Newby BZ; Chilian WM; Yin L
    Basic Res Cardiol; 2017 Jul; 112(4):41. PubMed ID: 28540527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction.
    Swijnenburg RJ; Govaert JA; van der Bogt KE; Pearl JI; Huang M; Stein W; Hoyt G; Vogel H; Contag CH; Robbins RC; Wu JC
    Circ Cardiovasc Imaging; 2010 Jan; 3(1):77-85. PubMed ID: 19920031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin- and basic fibroblast growth factor-incorporated degradable stent: comparison with traditional transmyocardial revascularization.
    Zhang GW; Liu XC; Mphil YL; Zhao J; Shi RF; Zhao XB; Liu TJ; Lü F; Yang Q; He GW
    J Cardiovasc Surg (Torino); 2011 Apr; 52(2):261-70. PubMed ID: 21460777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats.
    Fang J; Chen L; Fan L; Wu L; Chen X; Li W; Lin Y; Wang W
    J Mol Cell Cardiol; 2011 Nov; 51(5):839-47. PubMed ID: 21763697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated mice.
    Chiotti K; Choo SJ; Martin SL; Reichert C; Grass TM; Duran CM; Coffin JD
    Coron Artery Dis; 2000 Oct; 11(7):537-44. PubMed ID: 11023241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of miR-34c in high glucose-insulted mesenchymal stem cells leads to inefficient therapeutic effect on myocardial infarction.
    Kang HJ; Kang WS; Hong MH; Choe N; Kook H; Jeong HC; Kang J; Hur J; Jeong MH; Kim YS; Ahn Y
    Cell Signal; 2015 Nov; 27(11):2241-51. PubMed ID: 26232617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.